THIS PAGE IS STILL UNDER CONSTRUCTION. PLEASE DO NOT USE THIS INFORMATION YET Lumateperone (US brand name Caplyta™) is a second-generation (“atypical”) antipsychotic with an FDA indication for the treatment of schizophrenia in adults. Related Pages Lumateperone (Caplyta™): Basic information Potential side effects of lumateperone (Caplyta™) handout References Lumateperone (Caplyta™) Prescribing Information Review articles Edinoff A,…